DMC is currently undertaking trials, which addressed the levels of silicone oil used to lubricate the barrel/stopper in the prefilled drug market. The free suspension of oil is an ongoing issue and one that DMC will reduce/eliminate during trials – September 2016
DMC’s copolyester BPA free syringe is gaining traction in the market amongst the Kit Packers and Prefilled Drug providers, where we are seeing an increased demand month on month – August 2016
DMC undertakes the development of a heart positioning device that will complement its current cardiovascular accessory portfolio for open heart surgery – April 2016
CE mark approval for the SureSafe™ received on the 14th April 2016
DMC undertakes the development of a customer specified syringe range for the European/Australian markets. DMC will deliver to the rest of the world – March 2016
Agents appointed for Hong Kong, Singapore, Japan, Mexico, UAE, Iran, Saudi Arabia, New Zealand, Iraq & Kuwait – March 2016
First deliveries of SureSafe™ to Carson CA in February 2016.
During 2015 DMC entered a joint collaboration with Eastman Chemical and a major Multi-National in trialling the NuGen™ for a new prefilled drug delivery syringe. An extensive report was issued on the trials with NuGen™ being the syringe of choice – December 2015
PCT patent application for the SureSafe™ automatic retractable syringe range – June 2015.
FDA 510K approval for the Automatic Retractable Syringe “Options” in November 2015.
The latter part of 2014 and the first half of 2015 were spent further developing and perfecting the SureSafe™ range of automatic retractable syringes (1ml, 3ml, 5ml & 10ml). This development is now complete – July 2015
Pat Jones is appointed as Financial Director at DMC medical – April 2015.
DMC Medical appoints MedPro Associates of Colorado to market, represent and solicit sales for the SureSafe™ automatic retractable syringe. This appointment effectively puts forty six dedicated sales reps directly in the market place, giving DMC the necessary national sales force in the U.S.
DMC Medical adds McKesson Medical-Surgical Inc to its portfolio of distributors in the U.S.
Eastman Chemical exhibits the NuGen™ syringe range during MD&M expo at Anaheim, California.
DMC Medical appoints MapleStar Medical Products LLC of Ada, Michigan as their exclusive U.S. Agent. MapleStar will promote and manage the distribution network on behalf of DMC for the SureSafe™ automatic retractable syringe range, which will be launched throughout the States in the latter part of 2014.
Eastman Chemical in conjunction with DMC Medical today issued a press release outlining the development and advantages of the NuGen™ syringes. The press release is to coincide with Eastman’s presence and product launch during Medica, Dusseldorf, Germany.
All trials have now been successfully completed where we successfully ran 1ml, 3ml, 6ml, 10ml, 20ml & 30ml. This range will be sold under the brand name NuGen™.
Trials of the Eastman Chemical material have commenced at our sister company DMC Medical Tech & Mfg Co. Ltd in HeYuan City.
Following a number of successful discussions DMC Medical have entered into a collaboration agreement with Eastman Chemical that will see DMC trial Eastman’s medical grade copolymer.
The BPA free polymer chosen has superior lipid & chemical resistance in addition to its toughness, clarity and suitability for EtO & Gamma sterilization. Should the trials prove successful, the resulting syringes should be suitable for the medical device & Pharma prefilled markets.